Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001244964 | SCV001418221 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 872 of the CEP290 protein (p.Ser872Leu). This variant is present in population databases (rs373341530, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. ClinVar contains an entry for this variant (Variation ID: 969581). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CEP290 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001577091 | SCV001804416 | uncertain significance | not provided | 2019-10-14 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002480831 | SCV002781932 | uncertain significance | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003426013 | SCV004117186 | uncertain significance | CEP290-related condition | 2024-01-31 | criteria provided, single submitter | clinical testing | The CEP290 c.2615C>T variant is predicted to result in the amino acid substitution p.Ser872Leu. The c.2615C>T variant was reported in the heterozygous state in one patient with retinitis pigmentosa; however, a second plausible causative variant was not identified in this patient’s CEP290 gene (Wang et al. 2014. 25097241). The p.Ser872Leu variant was also reported along with a second uncertain CEP290 variant in two siblings who presented with obesity; however both variants were found to be paternally inherited (Niazi et al. 2019. PubMed ID: 31488071). This variant is reported in 0.10% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Centre de Biologie Pathologie Génétique, |
RCV001252438 | SCV001428194 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001577091 | SCV002035699 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001577091 | SCV002037672 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001835220 | SCV002094282 | uncertain significance | Leber congenital amaurosis | 2020-01-22 | no assertion criteria provided | clinical testing |